Project
A Phase 1, dose-finding study of Debio 0123 as monotherapy in adult patients with advanced solid tumors, followed by an expansion part to assess safety and preliminary anti-tumor activity
Ongoing - recruitment active · 2024 until 2099
Hess Dagmar, Scherrer Julia, Quinter Janine
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Ongoing - recruitment active
Start Date
2024
End Date
2099
Financing
Industry
Labels
Phase I